MBK Partners Sells Luye Pharma Stake to Fellow PE Funds

In an unusual move, one private equity fund has sold its majority ownership in a China pharma to three other funds, a rare fund-to-fund transaction. MBK Partners, a PE group based in Korea, sold its 77% interest in Luye Pharma Group, a Singapore listed company that operates mainly in China. According to the Wall Street Journal , the transaction shows that investor funds have more investable capital than attractive targets, while public valuations are low by comparison. The selling price has not been disclosed. More details..... Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});